BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34021690)

  • 1. The type III secretion system effector EspO of enterohaemorrhagic Escherichia coli inhibits apoptosis through an interaction with HAX-1.
    Chatterjee S; Lekmeechai S; Constantinou N; Grzybowska EA; Kozik Z; Choudhary JS; Berger CN; Frankel G; Clements A
    Cell Microbiol; 2021 Sep; 23(9):e13366. PubMed ID: 34021690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.
    Berger CN; Crepin VF; Baruch K; Mousnier A; Rosenshine I; Frankel G
    mBio; 2012; 3(5):. PubMed ID: 23033475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection.
    Hemrajani C; Berger CN; Robinson KS; Marchès O; Mousnier A; Frankel G
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3129-34. PubMed ID: 20133763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A type III effector antagonizes death receptor signalling during bacterial gut infection.
    Pearson JS; Giogha C; Ong SY; Kennedy CL; Kelly M; Robinson KS; Lung TW; Mansell A; Riedmaier P; Oates CV; Zaid A; Mühlen S; Crepin VF; Marches O; Ang CS; Williamson NA; O'Reilly LA; Bankovacki A; Nachbur U; Infusini G; Webb AI; Silke J; Strasser A; Frankel G; Hartland EL
    Nature; 2013 Sep; 501(7466):247-51. PubMed ID: 24025841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EspO1-2 regulates EspM2-mediated RhoA activity to stabilize formation of focal adhesions in enterohemorrhagic Escherichia coli-infected host cells.
    Morita-Ishihara T; Miura M; Iyoda S; Izumiya H; Watanabe H; Ohnishi M; Terajima J
    PLoS One; 2013; 8(2):e55960. PubMed ID: 23409096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways.
    Santos AS; Finlay BB
    Cell Microbiol; 2015 Mar; 17(3):318-32. PubMed ID: 25588886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition of COPII trafficking is important for intestinal epithelial tight junction disruption during enteropathogenic Escherichia coli and Citrobacter rodentium infection.
    Thanabalasuriar A; Kim J; Gruenheid S
    Microbes Infect; 2013; 15(10-11):738-44. PubMed ID: 23747681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NleB/SseK effectors from
    El Qaidi S; Chen K; Halim A; Siukstaite L; Rueter C; Hurtado-Guerrero R; Clausen H; Hardwidge PR
    J Biol Chem; 2017 Jul; 292(27):11423-11430. PubMed ID: 28522607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The QseG Lipoprotein Impacts the Virulence of Enterohemorrhagic Escherichia coli and Citrobacter rodentium and Regulates Flagellar Phase Variation in Salmonella enterica Serovar Typhimurium.
    Cameron EA; Gruber CC; Ritchie JM; Waldor MK; Sperandio V
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29358334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Citrobacter rodentium type III secretion system effector EspO affects mucosal damage repair and antimicrobial responses.
    Berger CN; Crepin VF; Roumeliotis TI; Wright JC; Serafini N; Pevsner-Fischer M; Yu L; Elinav E; Di Santo JP; Choudhary JS; Frankel G
    PLoS Pathog; 2018 Oct; 14(10):e1007406. PubMed ID: 30365535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Type III Secretion System of Pathogenic Escherichia coli.
    Slater SL; Sågfors AM; Pollard DJ; Ruano-Gallego D; Frankel G
    Curr Top Microbiol Immunol; 2018; 416():51-72. PubMed ID: 30088147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function.
    Gao X; Wan F; Mateo K; Callegari E; Wang D; Deng W; Puente J; Li F; Chaussee MS; Finlay BB; Lenardo MJ; Hardwidge PR
    PLoS Pathog; 2009 Dec; 5(12):e1000708. PubMed ID: 20041225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment.
    Kim M; Ogawa M; Fujita Y; Yoshikawa Y; Nagai T; Koyama T; Nagai S; Lange A; Fässler R; Sasakawa C
    Nature; 2009 May; 459(7246):578-82. PubMed ID: 19489119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmonella, E. coli, and Citrobacter Type III Secretion System Effector Proteins that Alter Host Innate Immunity.
    El Qaidi S; Wu M; Zhu C; Hardwidge PR
    Adv Exp Med Biol; 2019; 1111():205-218. PubMed ID: 30411307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteropathogenic and enterohemorrhagic Escherichia coli type III secretion effector EspV induces radical morphological changes in eukaryotic cells.
    Arbeloa A; Oates CV; Marchès O; Hartland EL; Frankel G
    Infect Immun; 2011 Mar; 79(3):1067-76. PubMed ID: 21189318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Roles of the Antiapoptotic Effectors NleB and NleF from Enteropathogenic Escherichia coli.
    Pollock GL; Oates CVL; Giogha C; Wong Fok Lung T; Ong SY; Pearson JS; Hartland EL
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28138023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2.
    Pham TH; Gao X; Tsai K; Olsen R; Wan F; Hardwidge PR
    Infect Immun; 2012 Jun; 80(6):2133-40. PubMed ID: 22451523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.
    Wong AR; Pearson JS; Bright MD; Munera D; Robinson KS; Lee SF; Frankel G; Hartland EL
    Mol Microbiol; 2011 Jun; 80(6):1420-38. PubMed ID: 21488979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation.
    Pearson JS; Giogha C; Mühlen S; Nachbur U; Pham CL; Zhang Y; Hildebrand JM; Oates CV; Lung TW; Ingle D; Dagley LF; Bankovacki A; Petrie EJ; Schroeder GN; Crepin VF; Frankel G; Masters SL; Vince J; Murphy JM; Sunde M; Webb AI; Silke J; Hartland EL
    Nat Microbiol; 2017 Jan; 2():16258. PubMed ID: 28085133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type Three Secretion System in Attaching and Effacing Pathogens.
    Gaytán MO; Martínez-Santos VI; Soto E; González-Pedrajo B
    Front Cell Infect Microbiol; 2016; 6():129. PubMed ID: 27818950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.